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Introduction 
 
Maturity-onset diabetes of  the young (MODY) 
was distinguished from other types of  diabetes 
mellitus in 1970' (1). It is clinically characterized 
by nonketotic diabetes mellitus, a primary defect 
in the function of  the beta cells of  the pancreas, 
an onset before the age of  25 yr (usually in child-
hood or adolescence), and an autosomal dominant 
mode of  inheritance (2). MODY seems to be an 
attractive model for genetic studies because its 
well-defined mode of  autosomal dominant inher-
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itance with high penetrance, and its early onset age 
that aids the collection of  multigenerational pedi-
grees (3). The molecular genetic basis of  MODY 
started in the 1990s (4-6), showed that MODY is a 
heterogenous group of  monogenic disorders. To 
date, Online Mendelian Inheritance in Man 
(OMIM) has listed MODY1-11 based on impli-
cated genes (Table 1) (7). 
 
Table 1: Genetic classification and clinical phenotypes of the MODY subtypes 
 
MODY 
subtype 
Affected 
gene 
Affected protein Lqocus Gene function Primary defect 
Type 1 HNF4  
alpha 
Hepatocyte nuclear 
factor 4 alpha 
20q Transcription factor (Nuclear factor) Pancreas 
Type 2 GCK Glucokinase 7p15-
p13 
Hexokinase IV Pancreas/Liver 
Type 3 HNF1  
alpha / 
TCF1 
Hepatocyte nuclear 
factor 1 alpha 
12q24.2 Transcription factor (Homeodomain) Pancreas/Kidney 
Type 4 IPF1 Insulin promoter fac-
tor-1 
13q12.1 Transcription factor (Homeodomain) Pancreas 
Type 5 HNF1 beta 
/ TCF2 
Hepatocyte nuclear 
factor 1 beta 
17q12 Transcription factor (Homeodomain) Kidney/Pancreas 
Type 6 Neuro D1 Neurogenic differentia-
tion factor 1 
2q Transcription factor (bHLH) Pancreas 
Type 7 KLF11 Kruppel-like factor 11 2p25 Transforming growth factor-beta inducible-
early growth response 2. 
Pancreas 
Type 8 CEL Bile salt dependent 
lipase 
9q34.3 The endocrine cells of pancreas synthesize 
insulin and are involved in the pathogenesis 
of diabetes mellitus and exocrine cells are 
involved in the pathogenesis of pancreas. 
Pancreas 
Type 9 PAX4 Paired domain gene 4 7q32 Transcription factor (paired domain gene 4) Pancreas 
Type 10 INS Insulin 11p15.5. Beta cells of the islets of Langerhans NF-kappa-B 
Type 11 BLK Tyrosine kinase B-
Lymphocyte specific 
8p23-
p22 
Tyrosine kinase (B lymphocytes) MIN6 beta cells 
Adapted from Attiya et al (41)  
 
MODY-related genes that have been most com-
monly studied are the hepatic nuclear factor 4 al-
pha (HNF4α) (MODY1), glucokinase (GCK) 
(MODY2), the hepatic nuclear factor 1 alpha 
(HNF1α) (MODY3), the insulin promoter factor-
1 (IPF1) (MODY4) and the hepatic nuclear factor 
1 beta (HNF1β) (MODY5). They account for the 
majority of  MODY cases. For example, around 
32%, 52%, 10% and 6% of  cases in the UK were 
due to GCK, HNF1α, HNF4α, and HNF1β, re-
spectively (8). To adding the heterogeneity of  
MODY, diverse mutations were reported in each 
pathogenic gene. For GCK only, more than 600 
mutations have been described so far, leading to 
both hypoglycemia and hyperglycemia (9). Fur-
thermore, 16–45% of  the cases of  MODY cannot 
be sorted into these 11 subtypes, and be named 
MODY-X. More studied are needed to discover 
the unknown MODY locus or loci (10). 
Population studies revealed that heterogeneity also 
exists within MODY patients of different ethnic 
groups (11). For example, MODY2 (GCK) and 
MODY3 (HNF-1a) were found to account for 
more than 80% of cases in a cohort of U.K. Cau-
casians (12). However, in Hong Kong Chinese, 
these two forms of MODY were found to be re-
sponsible for a mere 4% and 5%, respectively (13). 
Except for the subtype heterogeneity, the muta-
tions of the same MODY subtype that has been 
reported in different populations are usually dif-
ferent and hard to be confirmed (11). 
To help the overall understanding of MODY-re-
lated pathologic mutations, we studied a large Chi-
nese MODY family. We use whole genome scan 
Iran J Public Health, Vol. 45, No.2, Feb 2016, pp. 170-178 
172                                                                                                        Available at:    http://ijph.tums.ac.ir  
and candidate gene sequencing to identify the 
MODY subtype of the family, and to find the re-
lated gene mutation. 
 
Materials and Methods 
 
Pedigree assessment 
A large Han pedigree in 2012 in Shandong Prov-
ince, northern China, was identified through a 
proband with typical MODY features (Fig. 1). 
The pattern of inheritance within the family is 
consistent with autosomal-dominant inheritance. 
In total, 9 individuals in this three-generation fam-
ily met MODY diagnostic criteria (14) and 
showed a broad spectrum of clinical diabetic phe-
notypes. The other 21 family members are unaf-
fected. This study obtained signed informed con-
sent from 9 affected and 17 unaffected family 
members or their guardians, and 1000 adult volun-
tary blood donors. 
This study was approved by the Ethics Committee 
of the Institute of Basic Medicine of Shandong 
Academy of Medical Sciences. 
 
 
 
Fig. 1: Pedigree of the MODY family from Changqing, Shandong, China 
DNA extraction and sample pooling 
Peripheral venous blood samples were collected 
from 9 MODY patients in the family (2 males and 
7 females, age 15-54), 17 unaffected family mem-
bers (8 males and 9 females, age 7-77) and 1000 
apparently healthy blood donors randomly se-
lected from the Blood Center of Shandong prov-
ince (702 males and 298 females, aged 17-55). Ge-
nomic DNA was extracted by a modified phenol-
chloroform method as described before (15). The 
pooled DNA samples of (i) MODY patients in 
the family (n=9), (ii) unaffected family members 
(n=17), and (iii) unrelated population controls 
(n=1000), were obtained by combining equal 
amounts of DNA from each individual (16).  
 
Genotyping and statistics 
A panel of 400 microsatellite marker loci was gen-
otyped in three pooled DNA samples, using ABI 
PRISM Linkage Mapping Set MD-10 (ABI). The 
set has fluorescence-labeled PCR primer pairs for 
400 highly polymorphic dinucleotide-repeat mi-
crosatellite markers chosen from the Geneth on 
human genetic linkage map on both autosomal 
and sex chromosomes, with an average spacing of 
10cM (17). Polymerase Chain Reaction (PCR), 
electrophoresis and genotyping analysis were as 
described before (15). Fifteen-μL PCR mixture 
contained 20 ng of genomic DNA, 1.5mM MgCI2, 
10x reaction buffer, 0.2mM of each dNTP, 0.3 
μM of each primer, and 1U of Taq polymerase. 
Amplification was performed on a Gene Amp 
9700 thermo cycler (Applied Bio systems) with 
the following parameters: 95 ℃ for 12 min initial 
denaturation, followed by 94 ℃ 15 sec, 55 ℃ 15 
sec, 72 ℃ 30 sec, 10 cycles; then 89 ℃ 15 sec, 55 ℃ 
15 sec, 72 ℃ 30 sec, 20 cycles, then 72 ℃ 10 min, 
and 4 ℃ hold. Electrophoresis was carried out on 
ABI PRISM 3100 Avant Genetic Analyzer, by 
mixing up to 9 PCR products simultaneously, 
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which had no overlap of products of the same size 
range labelled with the same dye. Genotyping was 
performed with Gene Mapper 3.5 software (Ap-
plied Biosystems). 
The predicted allele frequencies of microsatellites 
in each DNA pool were calculated as Allele Fre-
quency=fluorescence peak height of each al-
lele/the sum of fluorescence peak height of all al-
lele at the marker. Allele Frequency was converted 
into allele counts and the statistical significance 
was calculated with CLUMP24, a DOS executable 
with C source code based on Monte Carlo me-
thod for assessing significance of case-control as-
sociation studies with multi-allelic markers 
(http://www.davecur-
tis.net/dcurtis/software.html) (18). To reduce 
false positive error, the threshold of fluorescence 
signal was set as 30 units. A threshold of P<0.01 
was considered statistically significant.  
 
Sequencing and alignment for HNF-1β 
Primers for nine exons of HNF-1β (listed in Table 
2) were designed using Primer Premier 5.0 soft-
ware (http://www.premierbiosoft.com). PCR in a 
50 μl volume was performed with 5 μl genomic 
DNA (20 ng/μl), 5 μl of each primer (5 μM) and 
25 μl of Multiplex PCR Mix (Takara) was per-
formed on a GeneAmp9700 thermo cycler (ABI) 
with the following parameters: 94 ℃ for 5 min 
initial denaturation, followed by 94 ℃ 30 sec, 59 ℃ 
30 sec, 72 ℃ 60 sec, 45 cycles; then 72 ℃ 7 min, 
and 4 ℃ hold. After spin column purification, the 
reaction products was sequenced using BigDye® 
Terminator v3.1 Cycle Sequencing Kit (ABI). The 
purified labeled DNA fragments were sequenced 
by Applied Bio systems 3130 Genetic Analyzer 
(ABI) and analyzed by Sequencing Analysis Soft-
ware 5.2 (ABI). Sequence alignment was per-
formed using DNA man software. 
 
Results 
 
Genotyping of 400 microsatellite markers in 
three pooled DNA samples revealed D17S798 
as a positive marker to MODY  
Of all the 400 microsatellite marker loci in ABI 
PRISM Linkage Mapping Set MD-10 (ABI), 
D17S798 on chromosome 17q11.2 was related 
with MODY in the family. Allele frequencies for  
D17S798 were found to differ significantly 
(P<0.001) between the affected and unaffected 
family members, the affected and the healthy con-
trols, but not between unaffected family members 
and the healthy controls (P=0.94) (Fig. 2). No mi-
crosatellite markers on sex chromosomes showed 
significant differences for frequency between any 
of the DNA pooling samples, indicating an auto-
somal dominant inheritance that is one of the 
MODY criterions.  
 
Table 2: Primers for nine exons of HNF-1β 
 
Exon Forward Primer Reverse Primer 
Exon1-a CCAGGTCTTCTGCTCTCCAG GTGGCCGTTGGTGAGAGTAT 
Exon1-b TTTTCCGTCCTTGGAAAATG GACTTCTCTGGTGGGAAACG 
Exon2 TTTTGGCCTCATGTCTACCC AGAGGGCAAAGGTCACTTCA 
Exon3 TCGTCCGTTGTCTGTCTGTC GGTGAGCTTCTGGTGGTGTT 
Exon4 ACTCCCAACCAAGACTGCTG TAAGATCCGTGGCAAGAACC 
Exon5 ATTTCTTGTGGGTGGACAGG ATCAGCTCCAGAGCGACAAT 
Exon6 TCCCAAAGTGCTGGGATTAC CCCAAGTTTTCCAACCAAGA 
Exon7 TCCCATGGAATCTCCTGTGT ACCCAGAGAGGGAAAGTGGT 
Exon8 AGATGGGAGCTATGGTGTGG AACAACAGGGAGCCTCAGAA 
Exon9-a TTGGGCATCATCTCCCTTAG TTTTCGCATCAGTTTGTTCG 
Exon9-b CTCCCACGATGTCAAGGACT AGAGGACAAGGGGCTTCACT 
Exon9-c GTGCAATTTCCCCTCTGTGT GAACCATGGCAGGGAAAGTA 
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Fig. 2: Genotyping for microsatellite marker loci 
D17S798 in the three DNA pools 
2a. Peak heights of D17S798 
2b. Allele frequency estimates for D17S798 
 
The mutation of C77T in exon 1 of HNF-1β 
gene was associated with MODY5 in the 
family 
Close to D17S798 (17q11.2), there is a known 
MODY-related gene on 17q12, hepatocyte nuclear 
factor-1β (HNF-1β). The differences of allele fre-
quencies for the D17S798 mentioned above impli-
cated that the affected family members can be 
sorted as the MODY5 subtype. A single nucleo-
tide variant (SNV) of C77T in the 5ˊ-terminal 
non-coding region of exon 1 of HNF-1β was re-
lated to MODY5 in the proband by sequencing 
and alignment analysis (Fig. 3).  
 
 
 
Fig. 3: Sequence analysis of exon 1 of HNF-1β gene 
in the proband. 
The arrow indicates C77T in exon 1 of HNF-1β gene 
 
Discussion 
 
In the current study, allelic frequency of marker 
D17S798 on chromosome 17q11.2 was found to 
be related to MODY in the Chinese family. The 
known MODY-related gene near D17S798 is 
HNF-1β, implicating the patients in the family 
were MODY5 subtype. Further sequencing and 
alignment analysis found that a single nucleotide 
variant (SNV) of C77T in the 5ˊ-terminal non-
coding region of exon 1 of HNF-1β was related to 
MODY5 in the proband.  
MODY is an entity of several monogenic disor-
ders, and 11 genes have been associated to differ-
ent MODY subtypes: MODY1-HNF4α, MO-
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DY2-GCK, MODY3-HNF1α, MODY4-PDX1, 
MODY5-HNF1β, MODY6-NEUROD1, MO-
DY7-KLF11, MODY8-CEL, MODY9-PAX4, 
MODY10-INS, MODY11-BLK (7). MODY-re-
lated genes are being found continuingly, eg. 
MODY12-ABCC8 (19) and MODY13-KCNJ11 
(20). Still, a large part of MODY cases are labeled 
as “MODYX”, which means their genetic factors 
remain unclear and wait to be found. Another re-
search interest in the MODY studies is heteroge-
neous across populations. The relative prevalence 
of each subtypes varied (21, 22). In European 
populations, MODY2 (the most prevalent form in 
French families) (21) and MODY3 (the most pre-
valent form in British families) (22) are the two 
most prevalent forms. In Danish kindred clinically 
diagnosed as MODY, a relative prevalence of 36% 
of MODY3, 10% of MODY2 and 3% of MO-
DY1 were reported (23). In Spain, relative fre-
quencies in the MODY group were 80% MODY2, 
8.5% MODY3 and 1% MODY5 (24). The other 
MODY subtypes are rarely described in European 
studies. However, the studies in other continents 
reported that MODY2 and MODY3 are less preva-
lent. For example, MODY2 and MODY3 mutations 
were accounted for 13% and 8.7% in 23 Brazilian 
families only (25). Similarly, in Asia, MODY2 and 
MODY3 do not explain the majority of MODY 
cases (26-28). Yorifuji et al. found in 79 MODY 
Japanese patients, type 2 and type 3 accounts for 
about 36.7% (11 plus 18). Next most prevalent were 
MODY 5 (6 patients) and MODY 1 (3 patients) (26). 
In a cohort of 27 MODY Korean patients and 17 
patients with early onset type 2 diabetes, MODY2 
and MODY 3 variants were found in only 3 patients 
(including 1 MODY patient) (27). In China particu-
larly, a comprehensive study on 146 Hong Kong 
Chinese MODY families found 13 families had 
MODY3 mutations (9%), 2 had MODY2 mutations 
(1%). No MODY1 mutation was found. The au-
thors concluded that the majority of Chinese MO-
DY patients are due to yet unknown genes (29). 
Compared to MODY 1-3, MODY 5 is less studied. 
Wang et al. screened in 154 unrelated probands 
from early onset and multiple affected diabetes Chi-
nese pedigrees and found only two patients carried 
mutation of HNF-1β gene (30). Here, we reported a 
large MODY5 family found in the northern China, 
as a supplement to the above two Chinese study 
which are based in the southern China. 
HNF-1β gene (Gene ID: 6928) is located in chro-
mosome 17:37686432-37745247, encoded a pro-
tein of 557 amino acids in length (http://asia.en-
sembl.org/). Many different mutations in HNF-1β 
have been associated with MODY5 (31-33). Mis-
sense mutations that caused protein sequence 
changes were reported in different populations, 
e.g. M160V in Australian (31), P239R in Roma-
nian (34), L264S in Japanese patients (32), P159L 
in Korean patients (35) and S36F in Chinese pa-
tients (30). A frame-shift mutation, c.C1304del 
was found in Italy patients, which resulted in a 
truncated protein (36). Monoallelic loss of the en-
tire HNF1B gene were reported in Merman pa-
tients who showed more severe clinical symptoms 
other than diabetes, such as pancreas dysplasia, 
exocrine insufficiency, genital defects and mental 
retardation (37). In the systematic review of HNF-
1β anomalies related to MODY5 (38), the detec-
tion rate of HNF-1β anomalies was 1.4% among 
MODY cases (1.4%) and 41.2% among MODY 
cases with renal structure anomalies. Mutations 
were strikingly located within the DNA binding 
domain and spread among exons of the DNA 
binding domain with exons 2 and 4 were the hot-
test spots. However, in our MODY family an ex-
on 1 mutation was implicated. This novel SNV is 
located in the 5ˊ-terminal non-coding region of 
exon 1. The function of the 5ˊ non-coding region 
of eukaryotic mRNA and its binding proteins has 
not been extensively studied. Generally, the 5ˊ 
non-coding region plays a crucial role in the pro-
tein translation by forming secondary structure 
and providing binding sites for the ribosome and 
translation factors (39). Methylation of this region 
also affects translation (40). Therefore, we hy-
pothesize that the change from a “methylate-able” 
base C to a “non-methylate-able” base T in the 
5ˊnon-coding region of HNF-1β may change tran-
scription levels by altering the mRNA secondary 
structure and influence the binding sites for ribo-
some and/or translation factors. 
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Conclusion 
 
The SVP of C77T in the 5ˊnon-coding region of 
HNF-1β was related to MODY5 in the Chinese 
family studied. Previously detected mutations 
mainly indicated pathology resulting from the rela-
tion between HNF-1β protein structure/function 
and primary insulin secretory defects. As this nov-
el mutation is in a non-coding region of the gene 
it suggests that regulation of the gene may be wor-
thy of attention in studying the pathological me-
chanism of MODY or diabetes. 
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